MoonLake Immunotherapeutics CSO Kristian Reich sells 43,700 shares for $877,933
MLTX•Insider sale reported by chief scientific officer
- MoonLake Immunotherapeutics Chief Scientific Officer Kristian Reich reported selling 43,700 Class A ordinary shares on July 20, 2026.
- The sale was priced at $20.09 per share on a weighted-average basis.
- Indirect holdings fell to 2,764,746 shares following the transaction.
- Direct holdings totaled 35,389 shares after the sale.
Related News
Goodyear Tire & Rubber Co - To Permanently Close Fayetteville, North Carolina Manufacturing Facility - SEC Filing
GT•
Upland Software Appoints Jennifer Simon As Chief Financial Officer
UPLD•
